Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $79.9800 (1.14%) ($79.9800 - $81.2500) on Wed. Nov. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.12% (three month average) | RSI | 46 | Latest Price | $79.9800(1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(43%) IWM(42%) IWC(40%) IWO(40%) IBB(39%) | Factors Impacting LGND price | LGND will decline at least -2.06% in a week (0% probabilities). VXX(-19%) UNG(-8%) SHY(-6%) UUP(-4%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.06% (StdDev 4.12%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $80.45(-0.58%) | 10 Day Moving Average | $73.96(8.14%) | 20 Day Moving Average | $78.93(1.33%) | To recent high | -25.7% | To recent low | 29.4% | Market Cap | $1.285b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |